Taysha Gene Therapies, Inc. TSHA Change In Fair Value Of Term Loan
Change In Fair Value Of Term Loan at other companies
Other financials
Where this comes from
Reported directly by Taysha Gene Therapies, Inc. in its filing.
Tagged under the XBRL concept tsha:ChangeInFairValueOfTermLoan.
The official record: Taysha Gene Therapies, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Taysha Gene Therapies, Inc.'s change in fair value of term loan.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Taysha Gene Therapies, Inc.'s change in fair value of term loan?
- Taysha Gene Therapies, Inc. (TSHA) reported change in fair value of term loan of $1.47M in Q1 2026.
- How has Taysha Gene Therapies, Inc.'s change in fair value of term loan changed year-over-year?
- Taysha Gene Therapies, Inc.'s change in fair value of term loan decreased by 3.9% year-over-year, from $1.53M to $1.47M.
- What is the long-term trend for Taysha Gene Therapies, Inc.'s change in fair value of term loan?
- Over 2 years (2023 to 2025), Taysha Gene Therapies, Inc.'s change in fair value of term loan has grown at a 100.3% compound annual growth rate (CAGR), from $1.54M to $6.17M.
- What does change in fair value of term loan mean?
- This metric captures the non-cash impact of adjusting the carrying value of debt obligations to their current fair market value at the end of a reporting period. These adjustments are typically driven by changes in market interest rates, credit spreads, or specific contractual terms associated with the debt instrument. It serves as an indicator of how external market conditions affect the valuation of the company's long-term liabilities.